PTPRJ and gastric cancer: Our study revealed that CD148 exerted onco-suppressing function by dephosphorylating EGFR on Y1173, Y1068, and Y1092 and inhibiting the MEK/ERK and PI3K/AKT pathways in gastric cancer.